Cardiometabolic diseases (CMD) have shared properties and causes. Insulin resistance is a risk factor and characteristic of CMD and has been suggested to be modulated by gut microbiota (GM) derived plasma metabolites. As diet is among the most important modulators of GM, we performed a systematic review of the literature to assess if CMD can be modulated via dietary interventions targeting GM.